| Reference | FOI 2026/1568 |
|---|---|
| Description | GP prescribing guidance for cross sex hormones |
| Date Requested | 20/01/2026 |
| Date Replied | 16/02/2026 |
| Category | - |
Under the Freedom of Information Act 2000 I am requesting the following information please advise what national or international guideline were used by the Indigo Gender service to produce prescribing guidance for GPs e.g. shared care agreements, directed/ local enhanced services or prescribing guidelines. This includes advice given to GPs on prescribing oestrogen or testosterone (drug preparations and dose titration), blood monitoring and monitoring for adverse effects.
GMMMG hosts some of the Indigo Service’s shared care protocols (SCPs) which include the references used to develop them. Please view here:
NHS Greater Manchester does not hold any further information other than what is described in the SCPs hosted on GMMMG; this is because NHS England are the commissioners of the Indigo service. Therefore, it will be necessary to direct your request to NHS England for any further information you seek. Please find below a link to their website and information about how to make a Freedom of Information request.
NHS England » Freedom of Information Act and Environmental Information Regulations
To assist you please find below, a link to The provision of non-surgical Gender Identity Services specification available on the NHS England website.
service-specification-gender-dysphoria-services-non-surgical-oct-2022.pdf
